Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank13
3Y CAGR-56.5%
5Y CAGR-44.0%
Year-over-Year Change
Research and development spending
3Y CAGR
-56.5%/yr
vs -9.3%/yr prior
5Y CAGR
-44.0%/yr
Recent deceleration
Acceleration
-47.2pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $280000.00 | -8.8% |
| 2024 | $307000.00 | +448.2% |
| 2023 | $56000.00 | -98.3% |
| 2022 | $3.39M | -31.3% |
| 2021 | $4.94M | -3.3% |
| 2020 | $5.11M | -11.0% |
| 2019 | $5.74M | +14.6% |
| 2018 | $5.01M | +158.7% |
| 2017 | $1.94M | +310.2% |
| 2016 | $472000.00 | - |